Comprehensive Evidence-Based Guidelines for Regenerative Therapies in the Management of Chronic Low Back Pain: 2025 Update from the American Society Of Interventional Pain Physicians (ASIPP).

Based on current evidence, lumbar intradiscal injections of platelet-rich plasma (PRP) and mesenchymal stem cells (MSCs) are supported by Level III evidence. Lumbar epidural PRP injections are also supported by Level III evidence, while PRP injections for lumbar facet joints and sacroiliac joints are supported by Level IV evidence. Given the emerging status of biologic therapies and the limited quality of existing studies, the panel provides moderate, consensus-based recommendations for the use of all biologics in the lumbar spine.

Authors

Institutions

Publication Details

Journal
PubMed
Published
2025-12-01
Primary Topic
Spine and Intervertebral Disc Pathology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Comprehensive Evidence-Based Guidelines for Regenerative Therapies in the Management of Chronic Low Back Pain: 2025 Update from the American Society Of Interventional Pain Physicians (ASIPP).

J Hirsch, Lady Christine Ong Sio, Devi E. Nampiaparampil, Paul J. Christo et al.
PubMed
Spine and Intervertebral Disc Pathology
article

Comprehensive Evidence-Based Guidelines for Regenerative Therapies in the Management of Chronic Low Back Pain: 2025 Update from the American Society Of Interventional Pain Physicians (ASIPP).

J Hirsch, Lady Christine Ong Sio, Devi E. Nampiaparampil, Paul J. Christo, Mahendra Sanapati, Sanjay Bakshi, Nebojša Nick Knežević, Annu Navani, DAJIE WANG, Sairam Atluri, Joseph A Cabaret, Theodore T. Sand, Riya Navani, Alexander Bautista, Sheri L. Albers, Vivek Manocha, Adam M. Kaye, Robert P. Farhat, Amol Soin, Aaron K Calodney, Shounuck Patel, Saloni Shah, Kenneth D. Candido, Shivam Shah, Navneet K. Boddu, Alaa Abd-Elsayed, John Santa Ana, Sheldon Jordan, Tom Nabity, Anss Annie Augustine, Miles R Day, Vidyasagar Pampati, Alan D Kaye, Laxmaiah Manchikanti, Michael Khadavi
article en

Abstract

Based on current evidence, lumbar intradiscal injections of platelet-rich plasma (PRP) and mesenchymal stem cells (MSCs) are supported by Level III evidence. Lumbar epidural PRP injections are also supported by Level III evidence, while PRP injections for lumbar facet joints and sacroiliac joints are supported by Level IV evidence. Given the emerging status of biologic therapies and the limited quality of existing studies, the panel provides moderate, consensus-based recommendations for the use of all biologics in the lumbar spine.

PubMedVol. 28(S7)
University of the Pacific (US), Harvard University (US), University of Louisville (US), Johns Hopkins University (US), Oakland University (US), Johns Hopkins Medicine (US), University of Illinois Chicago (US), Massachusetts General Hospital (US), Advocate Illinois Masonic Medical Center (US), Pain Management Centers Of America (US), Louisiana State University Health Sciences Center Shreveport (US), Stanford University (US)
Good health and well-being
Openalex Percentile: Top 28%
Spine and Intervertebral Disc Pathology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.